Zimmer Biomet Holdings, Inc. (ZBH)
| Market Cap | 35.96B |
| Revenue (ttm) | 7.09B |
| Net Income (ttm) | 567.70M |
| Shares Out | 208.00M |
| EPS (ttm) | 2.73 |
| PE Ratio | 63.28 |
| Forward PE | 22.27 |
| Dividend | $0.96 |
| Dividend Yield | 0.56% |
| Trading Day | May 7 |
| Last Price | $172.49 |
| Previous Close | $173.23 |
| Change ($) | -0.74 |
| Change (%) | -0.43% |
| Day's Open | 173.03 |
| Day's Range | 172.31 - 174.84 |
| Day's Volume | 991,444 |
| 52-Week Range | 108.02 - 180.36 |
Zimmer Biomet Holdings Inc (NYSE: ZBH) shares took a hit today despite first-quarter results beating the consensus. Adjusted diluted EPS of $1.71, grew 0.6% Y/Y, and surpassed Wall Street's estimate of ...
Zimmer Biomet's (ZBH) core hip and S.E.T. business registers growth in the reported quarter.
Zimmer (ZBH) delivered earnings and revenue surprises of 13.25% and 5.94%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
WARSAW, Ind., May 4, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2021.
Zimmer Biomet (ZBH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zimmer Biomet's (ZBH) first-quarter 2021 revenues are likely to have been adversely impacted due to pandemic-led lower elective procedure volumes.
WARSAW, Ind., April 27, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that President and CEO Bryan Hanson and Exec...
Here are five orthopedic device stocks, Integra (IART), Conformis (CFMS), SeaSpine (SPNE), Zimmer Biomet (ZBH), Orthofix (OFIX), which are expected to continue their run over the next few months.
WARSAW, Ind., April 20, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced U.S. Food and Drug Administration 510(k) cle...
Douglas C. Lane's Sarat Sethi on his top three reopening stock picks
Sarat Sethi, managing partner at Douglas C. Lane, joined "Squawk Box" on Thursday to explain his top three reopening stock plays: Zimmer Biomet, Diageo and American Express.
WARSAW, Ind., April 6, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter earnings conference call will be webcast on Tuesday, May 4, 2021 at 8:30 a.m.
Zimmer Biomet's (ZBH) latest portfolio enhancement is aimed at improving patient outcome throughout the entire treatment process.
WARSAW, Ind., March 31, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today introduced ZBEdge™ Connected Intelligence Suite of cur...
WARSAW, Ind., March 31, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced key updates to the Company's Executive Leade...
WARSAW, Ind., March 19, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Ivan Tornos has been appointed to the n...
For Zimmer Biomet (ZBH), the spin-off is an important step forward to its transition into a more streamlined business with a focus on more optimized resource allocation.
WARSAW, Ind., March 11, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the...
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
In the Americas, there is increased pressure on Zimmer Biomet (ZBH) procedural volume as a result of surge in infections.
Zimmer Biomet (ZBH) states that continued pressure from the COVID-19 pandemic slowed the recovery of elective procedures in the fourth quarter.
Zimmer (ZBH) delivered earnings and revenue surprises of 2.43% and 0.57%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Zimmer Biomet Holdings (NYSE:ZBH) rose 0.8% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 8.26% over the past year to $2.11, which beat...
WARSAW, Ind., Feb. 5, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced its intention to spin off the Company's Spine ...
WARSAW, Ind., Feb. 5, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2020. The Company reported fourth...
On Friday, February 05, Zimmer Biomet Holdings (NYSE:ZBH) will release its latest earnings report. Benzinga's outlook for Zimmer Biomet Holdings is included in the following report.
Zimmer Biomet's (ZBH) patient volumes are expected to have increased significantly in the fourth quarter due to pent-up demand.
STOCKHOLM, Jan. 21, 2021 /PRNewswire/ -- Today, Bactiguard-coated Zimmer Biomet orthopaedic trauma implants received European regulatory clearance and CE mark. Preparations for registering the implants ...
WARSAW, Ind., Jan. 19, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Ellison (Ellie) M. Humphrey has been app...
Final Trades: Pfizer, Devon Energy, Zimmer & more
The "Halftime Report" traders give their top picks to watch for the second half.
WARSAW, Ind., Jan. 8, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Friday, February 5, 2021 at 8:3...
Zimmer Biomet (ZBH) is performing well in its priority areas like quality remediation, supply recovery efforts and product introductions.
Final Trades: Home Depot, Zimmer Holdings, Tractor Supply & more
The "Halftime Report" traders give their top picks to watch for the second half.
Owing to lack of clarity around the scope and duration of the coronavirus pandemic, Zimmer Biomet (ZBH) is unable to gauge the impact on its overall business in 2020.
WARSAW, Ind., Dec. 16, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the ...
WARSAW, Ind., Dec. 14, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that President and CEO Bryan Hanson and Execu...
TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Marvell and Campbell Soup.
Zimmer Biomet's (ZBH) mymobility with Apple Watch platform aids in transforming virtual patient care via the latest partnership with HSS.
Let's see if Zimmer Biomet (ZBH) stock is a good choice for value-oriented investors right now from multiple angles.
The benefits of reopening post-pandemic have not yet been factored in for these four stocks relative to their earnings, according to UBS analysts.
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
This latest development aligns with Zimmer Biomet's (ZBH) active portfolio management strategy and the ongoing transformation of business aimed at long-term growth.
LOS ANGELES--(BUSINESS WIRE)--Vance Street Capital LLC (“Vance Street”) is pleased to announce it has completed the sale of A&E Medical Corporation (“A&E Medical”) to Zimmer Biomet (NYSE: ZBH) (“Zimmer”...
WARSAW, Ind., Dec. 1, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today officially launched the Zimmer Biomet Foundation. The Fo...
Zimmer Biomet has exited the 3rd quarter better than expected, with tailwinds in hips and knees globally to drive top-line growth in years to come. The ROSA and Persona Revision segments have performed ...
Zimmer Biomet Holdings, Inc. (ZBH) CEO Bryan Hanson on Q3 2020 Results - Earnings Call Transcript
The company's recovery from the coronavirus pandemic was better than expected.
Zimmer Biomet (ZBH) registers stronger-than-expected recovery of elective procedures in the third quarter.
Zimmer (ZBH) delivered earnings and revenue surprises of 72.38% and 12.50%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Zimmer Biomet Holdings (NYSE:ZBH) were unchanged after the company reported Q3 results.
WARSAW, Ind., Nov. 6, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2020. The Company reported third quarter ...
About ZBH
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as pr... [Read more...]
| Industry Medical Devices | Founded 1927 |
| CEO Bryan Hanson | Employees 20,000 |
| Stock Exchange NYSE | Ticker Symbol ZBH |
Analyst Forecasts
According to 30 analysts, the average rating for Zimmer Biomet stock is "Buy." The 12-month stock price forecast is 190.50, which is an increase of 10.44% from the latest price.